NIA, JPND Announce Effort to Enhance Transatlantic Collaboration on Neurodegenerative Disease Research
Neuron with dendrites and nucleus
The NIA has teamed up with the EU Joint Programme on Neurodegenerative Disease Research (JPND) to improve collaborative science on neurodegenerative diseases. The two funding organizations recently announced the creation of a new effort to connect and support collaborations between researcher working in the field.
In 2017, NIH and JPND issued separate proposals for investigating common mechanisms and pathways in neurodegenerative diseases. Under the new agreement, researchers supported under the JPND call are encouraged to team up with researchers supported under the NIH call, and vice versa. The enhanced collaboration lays the groundwork for proposing joint activities like pilot experiments, data sharing and scientific workshops. The overall aim is to speed knowledge transfer between the trans-Atlantic research teams.
To date, four projects have been supported through NIH's funding opportunity, “PAS17-028 Common Mechanisms and Interactions Among Neurodegenerative Diseases (R01).” JPND supported ten research consortia through their call for “Multinational research projects for Pathway Analysis across Neurodegenerative Diseases.”
“This is a crucial time of expanding global interest and support for neurodegenerative disease research,” said Dr. Eliezer Masliah, director of the NIA’s Division of Neuroscience. “In our connected age, breakthroughs in Alzheimer’s, vascular dementia, Lewy body disease, frontotemporal dementia and other neurological disorders require teamwork, and we look forward to strengthening the scientific connections between talented researchers across the EU and the US.”
Researchers who sequenced the fecal samples of over 3,000 healthy volunteers recently described the so-called B2 enterotype, which is deficient in some anti-inflammatory bacteria. Today, they published more data, showing the high prevalence of this particular enterotype across multiple disease diagnoses.READ MORE
New research may explain why an antioxidant that protects the brain is also associated with deterioration in areas susceptible to Alzheimer’s disease. The antioxidant, superoxide dismutase or SOD1, improves cognition, but an Iowa State University research team found SOD1’s protective benefits dramatically weaken when levels of tau proteins – a hallmark of Alzheimer’s disease – increase.